ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 28 of 59
JMBS 2020, 5(5): 223–228
Social medicine and organization of health care

Commercialization Capability of R&D Results in Biomedical Field of Ukraine and Analysis of Related Foreign Experience

Pyatchanina T., Ogorodnyk A., Melnik-Melnikov P., Gerasymchuk S.

Rapid development of modern areas of biomedical science contributes to the increase of the implementation rate, of innovative products and services in medicine, in particular, clinical oncology. The purpose of the article is the comparative analysis of the experience of R&D results commercialization in biomedical sector of the developed countries and Ukraine. The study uses methods of structural and logical analysis and comparative content analysis. Commercialization fits the inventor interests in using intellectual property, provides its implementation, and reveals commercial advantages to continue scientific and innovative activity. Society is interested in successful commercialization and technology transfer in biomedical field that increase competitiveness level of health system. Such activity stimulates scientists to develop innovative products. In foreign countries, legal and organizational mechanisms have been created that stimulate of investment activities for conducting research in the biomedical science at universities and scientific institutions. The development of links in the field of commercialization of R&D results has become a priority of the innovation policy of many countries, and public-private partnerships are an effective tool for its implementation, as evidenced by the rising of national budgets, legislative initiatives and the development of new programs. The analysis of the foreign experience of technology transfer of medical and biological R&D results allows to highlight several points: the financial support of research institutes and universities is considered as an important function of the state; public financing of projects in the field of medicine and biology is carried out within a quite long period of time (often not less than10 years), and the purchase of equipment is not a central item of expenditures; assessment of the productivity of researchers is complemented by evaluating the performance of the departments responsible for research management and funding; quantitative indicators of research unit results are supplemented by expert assessments of the quality of research, effectiveness and safety of medical developments based on new knowledge and achievements of scientific and technological progress. Conclusion. In Ukraine, despite certain difficulties in recent years, the high scientific potential in the field of biomedical sciences provides an increase of the number of high-tech innovative scientific and technological developments. Taking into account the low innovative activity of scientific institutions and universities, commercialization requires a systematic state approach, the development of strategies, specific mechanisms, methods and forms

Keywords: commercialization, technology transfer, scientific and technical activities (R&D activities), innovative product, biomedical science

Full text: PDF (Eng) 268K

  1. Tsibulev PM, Korsun VF. Bariery na shliakhu komertsializatsii rezultativ naukovykh doslidzhen v Ukraini [Barriers to commercialization of research results in Ukraine]. Science and innovation. 2009; 5(6): 87-96. [Ukrainian]
  2. Melnik-Melnikov P, Pyatchanyna T, Ogorodnyk A. Analysis of foreign tech transfer offices experience for the effective tech transfer system formation in the Ukrainian scientific institutions. Science, Technologies, Innovations. 2019; 3(11): 62-69. [Ukrainian]
  3. Vazhytskyi SE, Shcherbak TI. Metodyka ta orhanizatsiia naukovykh doslidzhen [Methodology and organization of scientific research]. Sumy: SumDPU im. A.S. Makarenka; 2016. 260 s. [Ukrainian]
  4. Tsibulev PM, Chebotarov VP, Zinov VG, Suini Yu. Upravlinnia intelektualnoiu vlasnistiu [Intellectual property management]. К: КІС; 2005. s. 435-442.
  5. Novikova IE, Beduh OR, Zenova MV. Rozvytok systemy transferu tekhnolohii u KNU im. Tarasa Shevchenka v konteksti yevrointehratsii [Development of technology transfer system at KNU Taras Shevchenko in the context of European integration]. KNUTD Bulletin. 2016; 2(97): 63-70. [Ukrainian]
  6. Litvinova OV, Posylkina OV. Upravlinnia intelektualnymy resursamy u farmatsii v umovakh innovatsiinoho rozvytku [Management of intellectual resources in pharmacy in the conditions of innovative development]. Kh: NFaU; 2018. 360 p. [Ukrainian]
  7. Artamonova NO. Informatsiine zabezpechennia transferu medychnykh tekhnolohii yak suchasnyi komunikatsiinyi mekhanizm innovatsiinoi diialnosti [Information support of medical technology transfer as a modern communication mechanism of innovative activity]. Bibliotekoznavstvo. Dokumentoznavstvo. Informolohiia. 2009; 3: 56-66. [Ukrainian]
  8. Servoss J. The Early Tech Development Course: Experiential Commercialization Education for the Medical Academician. Acad Med. 2017; 92(4): 506-510. PMid:28351064 PMCid:PMC5367498
  9. The Bayh-Dole Act or Patent and Trademark Law Amendments Act (Pub. L. 96-517, December 12, 1980). Available from:
  10. International Co-operation in Research and Innovation. Available from:
  11. Lyashenko OM. Modeli komertsializatsii ta transferu tekhnolohii v umovakh hlobalnoho seredovyshcha [Models of commercialization and technology transfer in the global environment: monograph]. Ternopil; 2007. 489 p. [Ukrainian]
  12. Scientific and Innovative Activity of Ukraine: Statistical Collection. 2018. [Ukrainian]. Available from:]
  13. Koval I. [Problems of commercialization of intellectual property rights by higher education institutions]. The theory and practice of intellectual property. 2014; 4: 11-18. [Ukrainian]
  14. Denisyuk VA. Komertsializatsiia rezultativ naukovo-doslidnykh robit: problemy i perspektyvy [Commercialization of research results: problems and perspectives]. Bulletin of the National Academy of Sciences of Ukraine. 2006; 5: 45-50. [Ukrainian]